🔎 Trials Near Me

Home › NCT06919042

Shockwave in Postoperative Breast Reconstruction Fibrosis

Recruiting

A Prospective Single-center Study for Evaluation of the Effectiveness of Pulsed Acoustic Cellular Expression Technology on Post-Operative Soft Tissue Fibrosis.

Who can join

Ages 18 and older · Women

Full eligibility criteria
Inclusion Criteria:

* Subjects greater than 18 years of age.
* Subjects who have undergone plastic surgery procedures and present in the post-operative period with soft tissue firmness suggestive of subcutaneous/parenchymal fibrosis.

Exclusion Criteria:

* Subjects with cardiac pacemakers
* Other medical or psychiatric condition that may increase the risk associated with study participation, may complicate subject compliance, or may interfere with the interpretation of study results and, in the judgment of the Investigator, would make the subject inappropriate for entry into this study.
* Proximity of fibrotic tissue directly adjacent to bone
* Face/neck areas are excluded
* Patients who, in the opinion of the investigator, would not be compliant with the schedule of study visits

About the study

This study evaluates the potential for extracorporeal shockwave therapy to reduce post-operative soft tissue fibrosis.

What is being tested

Sponsor: Northwestern University · Participants: 100 · Started: Oct 1, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06919042

Locations in the U.S.

IllinoisLavin Pavilion Suite 2060, Chicago

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.